[Clinical test of noxiptilin in the scope of cooperative testing in 5 psychiatric hospitals].
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003986:Dibenzocycloheptenes / Q000009:adverse effects / Q000627:therapeutic use*; D005239:Fear / Q000187:drug effects; D006167:Guilt; D006212:Hallucinations / Q000188:drug therapy; D006801:Humans; D006998:Hypochondriasis / Q000188:drug therapy; D010259:Paranoid Disorders / Q000188:drug therapy; D011596:Psychomotor Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D013850:Thinking / Q000187:drug effects; D013997:Time Factors
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes
Die klinische Prüfung von Noxiptilin im Rahmen einer Gemeinschaftsprüfung in fünf psychiatrischen Krankenhäusern.